Methods of capturing sperm nucleic acids

US2016289735A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2016289735-A1
Application numberUS-201514672358-A
CountryUS
Kind codeA1
Filing dateMar 30, 2015
Priority dateMar 30, 2015
Publication dateOct 6, 2016
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A method is provided herein, wherein the method of capturing a sperm deoxyribo nucleic acid (DNA) in a sample, comprises contacting a lysis solution to the sample comprising at least a sperm cell or a sperm cell lysate to lyse the sperm cell. The sperm cell or sperm cell lysate comprises a protamine-DNA complex. The method further comprises applying at least a protamine-specific antibody to the lysed sperm cell, wherein the protamine-specific antibody binds to the protamine-DNA complex of the lysed sperm cell to form an antibody-protamine-DNA complex. The antibody binding is followed by capturing the antibody-protamine-DNA complex; and isolating and detecting the sperm DNA from the captured antibody-protamine-DNA complex.

First claim

Opening claim text (preview).

What is claimed is: 1 . A method of capturing a sperm deoxyribo nucleic acid (DNA) in a biological sample, comprising: contacting a lysis solution to the biological sample comprising at least a sperm cell or a sperm cell lysate comprising a protamine-DNA complex to lyse the sperm cell; applying at least a protamine-specific antibody to the lysed sperm cell, wherein the protamine-specific antibody binds to the protamine-DNA complex of the lysed sperm cell to form an antibody-protamine-DNA complex; capturing the antibody-protamine-DNA complex; and detecting the sperm DNA from the captured antibody-protamine-DNA complex. 2 . The method of claim 1 , further comprising removing or sequestering the lysis solution prior to applying the protamine-specific antibody. 3 . The method of claim 1 , wherein the lysis solution comprises a reducing agent, a detergent or combination thereof. 4 . The method of claim 3 , wherein the lysis solution comprises a reducing agent selected from dithiothreitol (DTT), tris(2-carboxyethyl)phosphine (TCEP) or combination thereof. 5 . The method of claim 3 , wherein the lysis solution comprises a detergent selected from sodium dodecyl sulfate (SDS). 6 . The method of claim 3 , wherein the lysis solution comprises 40 mM dithiothreitol (DTT), 0.5% to 2% sodium dodecyl sulfate (SDS) or combinations thereof. 7 . The method of claim 3 , further comprising applying a sequestration agent after cell lysis to sequester detergent prior to applying the protamine-specific antibody to the lysed sperm cell. 8 . The method of claim 7 , wherein the sequestration agent comprises ligand-activated core beads coated with size exclusion shell, alpha-cyclodextrin, size exclusion resin or combinations thereof. 9 . The method of claim 1 , wherein the protamine-specific antibody binds to the protamine-nucleic acid complex during incubation in a range from about 4° C. to about 37° C. 10 . The method of claim 1 , wherein the protamine-specific antibody binds to the protamine-nucleic acid complex during incubation at about 4° C. for a time in a range from about 10 minutes to 4 hrs. 11 . The method of claim 1 , wherein the capturing of the antibody-protamine-DNA complex is achieved by a capturing agent, wherein the capturing agent is pre-coupled with the protamine-specific antibody. 12 . The method of claim 11 , wherein the capturing agent comprises a secondary antibody, agarose beads, paramagnetic beads, protein A, streptavidin, sephadex, glass bead or combinations thereof. 13 . The method of claim 1 , wherein the capturing of the antibody-protamine-DNA complex is achieved by further adding a capturing agent, wherein the capturing agent binds to the protamine-specific antibody. 14 . The method of claim 13 , wherein the capturing agent comprises a secondary antibody, agarose beads, paramagnetic beads, protein A, streptavidin, sephadex, glass bead or combinations thereof. 15 . The method of claim 13 , wherein the capturing agent is a secondary antibody specific to the protamine-specific antibody. 16 . The method of claim 13 , wherein the captured antibody-protamine-DNA complex is washed to remove unbound material and purify the sperm DNA. 17 . The method of claim 16 , further comprising incubating the captured antibody-protamine-DNA complex in an ion exchange resin. 18 . The method of claim 17 , wherein the captured antibody-protamine-DNA complex is incubated at about 95° C. for at least about 10 minutes. 19 . The method of claim 1 , wherein a reporter moiety is coupled to the protamine-specific antibody and wherein the detection of the reporter moiety indicates the presence of sperm DNA in the sample. 20 . The method of claim 19 , wherein the reporter moiety comprises a chromophore moiety, a fluorescent moiety, a phosphorescence moiety, an affinity probe, a magnetic probe, a paramagnetic probe, a metallic probe or combinations thereof. 21 . The method of claim 1 , wherein the detection of the sperm DNA comprises one or more amplification reactions of the sperm DNA. 22 . The method of claim 21 , further comprising analyzing the amplified DNA. 23 . The method of claim 1 , wherein the biological sample further comprises epithelial cells, somatic cells, blood cells, or combinations thereof. 24 . The method of claim 1 , wherein the biological sample is selected from a forensic sample comprising sperm cells. 25 . A method of capturing sperm deoxyribonucleic acid (DNA) in a biological sample, comprising: providing the biological sample comprising at least a sperm cell, a partially lysed sperm cell or a sperm cell lysate, wherein the sperm cell, partially lysed sperm cell or sperm cell lysate comprises a protamine-DNA complex; contacting a lysis solution to the sample to lyse the sperm cell or partially lysed sperm cell; applying at least a protamine-specific antibody to the lysed sperm cell, wherein the protamine-specific antibody binds to the protamine-DNA complex of the lysed sperm cell to form an antibody-protamine-DNA complex; capturing the antibody-protamine-DNA complex by adding a capturing agent; and detecting the sperm DNA from the captured antibody-protamine-DNA complex by a DNA amplification reaction. 26 . A method of purifying deoxyribo nucleic acid (DNA) from a biological sample, comprising: providing the sample comprising a protamine-DNA complex; applying at least a protamine-specific antibody to the protamine-DNA complex to form an antibody-protamine-DNA complex; capturing the antibody-protamine-DNA complex using a capturing agent; and purifying DNA from the captured antibody-protamine-DNA complex.

Assignees

Inventors

Classifications

  • Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor · CPC title

  • C12Q1/6804Primary

    Nucleic acid analysis using immunogens (immunoassay G01N33/53) · CPC title

  • Single or double stranded nucleic acid binding proteins · CPC title

  • related to pregnancy or the gonads · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2016289735A1 cover?
A method is provided herein, wherein the method of capturing a sperm deoxyribo nucleic acid (DNA) in a sample, comprises contacting a lysis solution to the sample comprising at least a sperm cell or a sperm cell lysate to lyse the sperm cell. The sperm cell or sperm cell lysate comprises a protamine-DNA complex. The method further comprises applying at least a protamine-specific antibody to the…
Who is the assignee on this patent?
Gen Electric
What technology area does this patent fall under?
Primary CPC classification C12Q1/6804. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Thu Oct 06 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).